Apr 17 |
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
|
Mar 6 |
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
|
Feb 12 |
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
|
Feb 8 |
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
|
Feb 8 |
Q1 2024 Enanta Pharmaceuticals Inc Earnings Call
|
Feb 8 |
Enanta Pharmaceuticals, Inc. (ENTA) Q1 2024 Earnings Call Transcript
|
Feb 7 |
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
|
Feb 7 |
Enanta Pharmaceuticals Inc (ENTA) Reports Fiscal Q1 2024 Results: Royalty Revenue Declines Amid ...
|
Feb 7 |
Enanta Pharma GAAP EPS of -$1.58 misses by $0.35, revenue of $18M misses by $3.95M
|
Feb 7 |
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
|